270
Views
0
CrossRef citations to date
0
Altmetric
Hematology

Patient-Reported Outcomes After Ferric Carboxymaltose Treatment for Iron Deficiency Anemia: A Prospective Observational Study

, , ORCID Icon, , &
Pages 3291-3300 | Received 22 Mar 2023, Accepted 17 Jul 2023, Published online: 02 Aug 2023

References

  • Lopez A, Cacoub P, Macdougall IC, et al. Iron deficiency anaemia. Lancet. 2016;387:907–916.
  • Coad J, Pedley K. Iron deficiency and iron deficiency anemia in women. Scand J Clin Lab Invest Suppl. 2014;244:82–89.
  • Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123:615–624.
  • WHO. Iron Deficiency Anaemia Assessment, Prevention, and Control: A Guide for Programme Managers. Geneva: World Health Organization; 2001.
  • Coad J, Conlon C. Iron deficiency in women: assessment, causes and consequences. Curr Opin Clin Nutr Metab Care. 2011;14:625–634.
  • Kumar A, Sharma E, Marley A, et al. Iron deficiency anaemia: pathophysiology, assessment, practical management. BMJ Open Gastroenterol. 2022;9:e000759.
  • Sobrero A, Puglisi F, Guglielmi A, et al. Fatigue: a main component of anemia symptomatology. Semin Oncol. 2001;28:15–18.
  • Acaster S, Dickerhoof R, DeBusk K, et al. Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia. Health Qual Life Outcomes. 2015;13:60.
  • Cappellini MD, Comin-Colet J, de Francisco A, et al. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92:1068–1078.
  • Agrawal S, Kumar S, Ingole V, et al. Does anemia affects cognitive functions in neurologically intact adult patients: two year cross sectional study at rural tertiary care hospital. J Family Med Prim Care. 2019;8:3005–3008.
  • Haas JD, Brownlie T. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001;131:676S–688S.
  • Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390:1211–1259.
  • Shao Y, Luo W, Xu H, et al. The Efficacy of Ferumoxytol for Iron Deficiency Anemia: a Meta-Analysis of Randomized Controlled Trials. Acta Haematol. 2019;142:125–131.
  • Cançado RD, de Figueiredo PON, Olivato MCA, et al. Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia. Rev Bras Hematol Hemoter. 2011;33:439–443.
  • Seid MH, Derman RJ, Baker JB, et al. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol. 2008;199:435.e1–7.
  • Food and Drug Administration [homepage on the Internet]. INJECTAFER - ferric carboxymaltose injection, solution, Highlights of prescribing information. Available from: https://www.accessdata.fda.gov/spl/data/2e2e2ed2-9aa5-4466-96ca-989f7a8d3ba8/2e2e2ed2-9aa5-4466-96ca-989f7a8d3ba8.xml. Accessed January 16, 2023.
  • Cella D, Lai J-S, Chang C-H, et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94:528–538.
  • Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74.
  • Hays RD, Bjorner JB, Revicki DA, et al. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18:873–880.
  • Stephan A, Stadelmann VA, Leunig M, et al. Measurement properties of PROMIS short forms for pain and function in total Hip arthroplasty patients. J Patient Rep Outcomes. 2021;5:41.
  • Shaw BE, Syrjala KL, Onstad LE, et al. PROMIS Measures can be used to assess symptoms and function in long term Hematopoietic Cell Transplantation Survivors. Cancer. 2018;124:841–849.
  • Evans JP, Smith A, Gibbons C, et al. The National Institutes of Health Patient-Reported Outcomes Measurement Information System (PROMIS): a view from the UK. Patient Relat Outcome Meas. 2018;9:345–352.
  • Terwee CB, Peipert JD, Chapman R, et al. Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Quality of Life Research. 2021;30:2729.
  • Vadhan-Raj S, Strauss W, Ford D, et al. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. Am J Hematol. 2014;89:7–12.
  • Hetzel D, Strauss W, Bernard K, et al. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. Am J Hematol. 2014;89:646–650.
  • Herfs R, Fleitmann L, Kocsis I. Treatment of Iron Deficiency with or without Anaemia with Intravenous Ferric Carboxymaltose in Gynaecological Practices – a Non-Interventional Study. Geburtshilfe Frauenheilkd. 2014;74:81–88.
  • Boomershine CS, Koch TA, Morris D. A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose in Iron-Deficient Patients with Fibromyalgia. Rheumatol Ther. 2018;5:271–281.
  • Jose A, Mahey R, Sharma JB, et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial. BMC Pregnancy Childbirth. 2019;19:54.
  • Ford DC, Dahl NV, Strauss WE, et al. Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders. Clin Exp Gastroenterol. 2016;9:151–162.
  • García-López S, Bocos JM, Gisbert JP, et al. High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life. Blood Transfus. 2016;14:199–205.
  • Holzner B, Kemmler G, Greil R, et al. The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol. 2002;13:965–973.
  • Hansen E, Fonager K, Freund KS, et al. The impact of non-responders on health and lifestyle outcomes in an intervention study. BMC Res Notes. 2014;7:632.
  • Berlin NL, Hamill JB, Qi J, et al. Non-response Bias in Survey Research: lessons from a Prospective Study of Breast Reconstruction. J Surg Res. 2018;224:112–120.